Related Experiment Video
Updated: May 3, 2026

Isolating Brown Adipocytes from Murine Interscapular Brown Adipose Tissue for Gene and Protein Expression Analysis
Published on: March 12, 2021
Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPARβ/δ in HepG2 cells
Guanghua Luo1, Yuanping Shi1, Jun Zhang1
1Comprehensive Laboratory, The Third Affiliated Hospital of Soochow University, Changzhou 213003, PR China.
Abstract:
It has been demonstrated that apolipoprotein M (APOM) is a vasculoprotective constituent of high density lipoprotein (HDL), which could be related to the anti-atherosclerotic property of HDL. Investigation of regulation of APOM expression is of important for further exploring its pathophysiological function in vivo. Our previous studies indicated that expression of APOM could be regulated by platelet activating factor (PAF), transforming growth factors (TGF), insulin-like growth factor (IGF), leptin, hyperglycemia and etc., in vivo and/or in vitro. In the present study, we demonstrated that palmitic acid could significantly inhibit APOM gene expression in HepG2 cells. Further study indicated neither PI-3 kinase (PI3K) inhibitor LY294002 nor protein kinase C (PKC) inhibitor GFX could abolish palmitic acid induced down-regulation of APOM expression. In contrast, the peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) antagonist GSK3787 could totally reverse the palmitic acid-induced down-regulation of APOM expression, which clearly demonstrates that down-regulation of APOM expression induced by palmitic acid is mediated via the PPARβ/δ pathway.
Insights
Palmitic acid inhibits apolipoprotein M (APOM) gene expression in liver cells. This down-regulation is mediated through the peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) pathway.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Research
Background:
- Apolipoprotein M (APOM) is a vasculoprotective component of high-density lipoprotein (HDL), contributing to HDL's anti-atherosclerotic properties.
- Understanding APOM expression regulation is crucial for elucidating its in vivo pathophysiological roles.
- Previous research identified various regulators of APOM expression, including platelet-activating factor (PAF), transforming growth factors (TGF), insulin-like growth factor (IGF), leptin, and hyperglycemia.
Purpose of the Study:
- To investigate the effect of palmitic acid on APOM gene expression in HepG2 cells.
- To elucidate the molecular pathway(s) involved in palmitic acid-induced regulation of APOM expression.
Main Methods:
- HepG2 cells were treated with palmitic acid.
- The impact of palmitic acid on APOM gene expression was assessed.
- Specific inhibitors for PI-3 kinase (LY294002), protein kinase C (GFX), and peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) (GSK3787) were used to probe the underlying signaling pathways.
Main Results:
- Palmitic acid significantly inhibited APOM gene expression in HepG2 cells.
- Inhibition of PI-3 kinase (PI3K) or protein kinase C (PKC) did not alter the down-regulation of APOM expression induced by palmitic acid.
- A PPARβ/δ antagonist (GSK3787) completely reversed the palmitic acid-induced down-regulation of APOM expression.
Conclusions:
- Palmitic acid down-regulates APOM gene expression in HepG2 cells.
- The mechanism of palmitic acid-induced APOM down-regulation involves the PPARβ/δ pathway.
- These findings highlight a novel regulatory role of fatty acids in APOM expression with potential implications for cardiovascular health.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cell Specific Gene Expression
Pharmacogenomics: Identification of New Drug Targets

